Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 3.55M $1.08B Sept. 30, 2015
Bank of America Corporation 2.01M $608.78M Sept. 30, 2015
JANE STREET 1.94M $588.49M Sept. 30, 2015
MORGAN STANLEY 1.84M $621.64M Dec. 31, 2015
Citi 1.65M $558.88M Dec. 31, 2015
Deutsche Bank Aktiengesellschaft 1.54M $467.06M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 1.40M $383.98M Sept. 30, 2014
UBS AG 1.40M $383.28M Sept. 30, 2014
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
BNP PARIBAS ARBITRAGE, SNC 1.33M $451.00M Dec. 31, 2015
UBS Group AG 1.17M $355.24M Sept. 30, 2015
Credit Suisse AG 1.13M $341.74M Sept. 30, 2015
JPMORGAN CHASE & CO 1.10M $336.25M Sept. 30, 2015
Archer Capital Management 980000 $81.15M March 31, 2012
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Wells Fargo & Company 480332 $162.51M Dec. 31, 2015
Barclays 470935 $159.18M Dec. 31, 2015
Bank of Nova Scotia 456000 $103.54M Dec. 31, 2013
Beaumont Financial Partners 451189 $154.95M March 31, 2015
SERENGETI ASSET MANAGEMENT 450000 $136.51M Dec. 31, 2014
HAP Trading 438300 $7.49M Sept. 30, 2014
Churchill Management 432945 $118.47M Sept. 30, 2014
SG Americas Securities 408768 $138.30M Dec. 31, 2015
Mirae Asset Global Investments 408643 $105.23M June 30, 2014

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M